Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-amido-C3-NH2 is a synthesized E3 ligase ligand-linker conjugate, which combines the cereblon ligand derived from Thalidomide with a linker utilized in PROTAC technology.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Thalidomide-O-amido-C3-NH2 is a synthesized E3 ligase ligand-linker conjugate, which combines the cereblon ligand derived from Thalidomide with a linker utilized in PROTAC technology. |
Synonyms | Thalidomide-O-amido-C3-NH2, Cereblon Ligand-Linker Conjugates 16, E3LigaseLigand-LinkerConjugates52 |
Molecular Weight | 388.37 |
Formula | C18H20N4O6 |
CAS No. | 2022182-57-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-amido-C3-NH2 2022182-57-4 ThalidomideOamidoC3NH2 Cereblon Ligand-Linker Conjugates 16 Thalidomide-O-amido-C-3-NH2 Cereblon Ligand-Linker Conjugates 16 Thalidomide O amido C3 NH2 E3LigaseLigand-LinkerConjugates52 inhibitor inhibit